imatinib mesylate

Generic: imatinib mesylate

Labeler: qilu pharmaceutical co., ltd.
NDC Directory HUMAN PRESCRIPTION DRUG ANDA Inactive Finished

Drug Facts

Product Profile

Brand Name imatinib mesylate
Generic Name imatinib mesylate
Labeler qilu pharmaceutical co., ltd.
Dosage Form TABLET
Routes
ORAL
Active Ingredients

imatinib mesylate 100 mg/1

Manufacturer
Qilu Pharmaceutical Co., Ltd.

Identifiers & Regulatory

Product NDC 67184-0532
Product ID 67184-0532_a41dbedd-ee4e-401c-b446-a435929ff903
Product Type HUMAN PRESCRIPTION DRUG
Marketing Category ANDA
Application Number ANDA212135
Listing Expiration 2026-12-31
Marketing Start 2022-06-21

Pharmacologic Class

Classes
bcr-abl tyrosine kinase inhibitors [moa] cytochrome p450 2d6 inhibitors [moa] cytochrome p450 3a4 inhibitors [moa] kinase inhibitor [epc]

Normalized Code Variants

Searchable formats for this product NDC code

Digits Only 671840532
Hyphenated Format 67184-0532

Supplemental Identifiers

RxCUI
403878 403879
UPC
0367184053322 0367184053223
UNII
8A1O1M485B

Packaging Origin

Original Packager
true

Resolved Product View

Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.

Resolved Identity

Brand Name imatinib mesylate (source: ndc)
Generic Name imatinib mesylate (source: ndc)
Application Number ANDA212135 (source: ndc)
Routes
ORAL
source: ndc

Resolved Composition

Strengths
  • 100 mg/1
source: ndc
Packaging
  • 90 TABLET in 1 BOTTLE (67184-0532-1)
  • 500 TABLET in 1 BOTTLE (67184-0532-2)
  • 30 BLISTER PACK in 1 CARTON (67184-0532-3) / 10 TABLET in 1 BLISTER PACK
source: ndc

Packages (3)

67184-0532-1 90 TABLET in 1 BOTTLE (67184-0532-1) 67184-0532-2 500 TABLET in 1 BOTTLE (67184-0532-2) 67184-0532-3 30 BLISTER PACK in 1 CARTON (67184-0532-3) / 10 TABLET in 1 BLISTER PACK

Ingredients (1)

imatinib mesylate (100 mg/1)

Linked Drug Pages (1)

imatinib mesylate ndc-match (0.9)

Raw FDA Data

View complete raw FDA NDC JSON payload 
{"route": ["ORAL"], "spl_id": "a41dbedd-ee4e-401c-b446-a435929ff903", "openfda": {"upc": ["0367184053322", "0367184053223"], "unii": ["8A1O1M485B"], "rxcui": ["403878", "403879"], "spl_set_id": ["82eb01e0-8685-4f06-8a72-7663e8ded38f"], "manufacturer_name": ["Qilu Pharmaceutical Co., Ltd."], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "90 TABLET in 1 BOTTLE (67184-0532-1)", "package_ndc": "67184-0532-1", "marketing_start_date": "20220621"}, {"sample": false, "description": "500 TABLET in 1 BOTTLE (67184-0532-2)", "package_ndc": "67184-0532-2", "marketing_start_date": "20220621"}, {"sample": false, "description": "30 BLISTER PACK in 1 CARTON (67184-0532-3)  / 10 TABLET in 1 BLISTER PACK", "package_ndc": "67184-0532-3", "marketing_start_date": "20220621"}], "brand_name": "imatinib mesylate", "product_id": "67184-0532_a41dbedd-ee4e-401c-b446-a435929ff903", "dosage_form": "TABLET", "pharm_class": ["Bcr-Abl Tyrosine Kinase Inhibitors [MoA]", "Cytochrome P450 2D6 Inhibitors [MoA]", "Cytochrome P450 3A4 Inhibitors [MoA]", "Kinase Inhibitor [EPC]"], "product_ndc": "67184-0532", "generic_name": "imatinib mesylate", "labeler_name": "Qilu Pharmaceutical Co., Ltd.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "imatinib mesylate", "active_ingredients": [{"name": "IMATINIB MESYLATE", "strength": "100 mg/1"}], "application_number": "ANDA212135", "marketing_category": "ANDA", "marketing_start_date": "20220621", "listing_expiration_date": "20261231"}